Free Functional Assessment
AI-powered root cause analysis & care plan
Start Free
Preferred vendor Β· Learn more
The TB-500 + Thymosin Alpha-1 stack combines systemic tissue healing with powerful immune modulation. TB-500 (Thymosin Beta-4 fragment) promotes cellular migration, reduces inflammation, and facilitates tissue repair throughout the body. Thymosin Alpha-1 (TA1) is an FDA-approved (outside US) immune peptide that enhances T-cell maturation, NK cell activity, and dendritic cell function. Together, these thymic peptides create a comprehensive protocol: TB-500 repairs damaged tissue while TA1 ensures the immune system supports recovery and prevents infection during the healing process.
TB-500 is a fragment of Thymosin Beta-4 that promotes systemic healing through actin sequestration (enabling cellular migration), anti-inflammatory signaling, and angiogenesis. Unlike BPC-157 which excels locally, TB-500 provides whole-body healing support. It allows immune and repair cells to migrate efficiently to damaged sites.
TA1 is the master regulator of adaptive immunity, maturing T-cells in the thymus, activating NK cells, and enhancing dendritic cell antigen presentation. During healing, proper immune function prevents opportunistic infections and coordinates the inflammatory-to-resolution transition. TA1 ensures TB-500 healing occurs in an optimally functioning immune environment.
| Protocol | Compound 1 | Compound 2 | Timing | Duration |
|---|---|---|---|---|
| Standard | TB-500 750mcg 3x/week | TA1 1.6mg 2x/week | TB: M/W/F, TA1: Tu/Th | 8-12 weeks |
| Loading | TB-500 2mg 2x/week (wk1-4) then 750mcg | TA1 1.6mg 3x/week | Alternating days | 12 weeks |
| Maintenance | TB-500 750mcg 2x/week | TA1 1.6mg 1x/week | M/Th | Ongoing |
| Panel | Markers | Timing |
|---|---|---|
| Immune Panel | CD4/CD8 ratio, NK cell count, lymphocyte subsets | Baseline, Week 6, Week 12 |
| Inflammatory | CRP, ESR, IL-6 | Baseline, Week 4, Week 8 |
| Basic | CBC with differential, CMP | Baseline, Week 6 |
Immune panels should show CD4/CD8 ratio normalization and NK cell count increases. CRP should decrease with TB-500.
Yes, as separate injections. However, many protocols alternate days (TB-500 M/W/F, TA1 Tu/Th) to spread injections and allow each peptide to work independently.
Standard cycle is 8-12 weeks. TB-500 loading phase (first 4 weeks) transitions to maintenance. TA1 can continue longer for sustained immune support, even indefinitely at 1x/week.
TB-500 and TA1 are both thymus-derived but serve different functions. TB-500 focuses on tissue repair through cellular migration and anti-inflammatory mechanisms, while TA1 optimizes immune function. Together they ensure the body can heal tissue and mount proper immune responses during recovery.
Yes, as separate injections. However, many protocols alternate days (TB-500 M/W/F, TA1 Tu/Th) to spread injections and allow each peptide to work independently.
Standard cycle is 8-12 weeks. TB-500 loading phase (first 4 weeks) transitions to maintenance. TA1 can continue longer for sustained immune support, even indefinitely at 1x/week.
TB-500 and TA1 are both thymus-derived but serve different functions. TB-500 focuses on tissue repair through cellular migration and anti-inflammatory mechanisms, while TA1 optimizes immune function. Together they ensure the body can heal tissue and mount proper immune responses during recovery.
Yes, as separate injections. However, many protocols alternate days (TB-500 M/W/F, TA1 Tu/Th) to spread injections and allow each peptide to work independently.
Standard cycle is 8-12 weeks. TB-500 loading phase (first 4 weeks) transitions to maintenance. TA1 can continue longer for sustained immune support, even indefinitely at 1x/week.